cyclosporine
Showing 51 - 75 of 338
Severe Aplastic Anemia Trial in United States (drug, procedure, radiation)
Active, not recruiting
- Severe Aplastic Anemia
- cyclosporine
- +8 more
-
Los Angeles, California
- +12 more
Feb 10, 2022
Heart and Lung Transplant Trial in Basel (cyclosporine)
Completed
- Heart and Lung Transplant
- cyclosporine
-
Basel, SwitzerlandNovartis
Feb 8, 2020
Chronic Graft-versus-host Disease Trial in Guangzhou (Mesenchymal stem cells, Glucocorticoids, cyclosporine)
Recruiting
- Chronic Graft-versus-host Disease
- Mesenchymal stem cells
- +2 more
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Dec 29, 2020
Hematologic Malignancies Trial in Lebanon (Stem Cell Transplant, G-CSF, Fludarabine)
Completed
- Hematologic Malignancies
- Stem Cell Transplant
- +5 more
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Oct 30, 2020
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia
Recruiting
- Acute Lymphoblastic Leukemia
- +11 more
- Cyclosporine
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 29, 2022
Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Stanford (biological, drug,
Completed
- Acute Myeloid Leukemia
- +6 more
- Anti-Thymocyte Globulin
- +5 more
-
Stanford, CaliforniaStanford University, School of Medicine
Jun 1, 2021
Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)
Active, not recruiting
- Sickle Cell Disease
- Graft Versus Host Disease
- Diphenhydramine
- +15 more
-
Washington, District of Columbia
- +6 more
Aug 4, 2021
Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia, Relapse Trial run by the NHLBI (Alemtuzumab (Campath ),
Completed
- Severe Aplastic Anemia, Refractory
- Severe Aplastic Anemia, Relapse
- Alemtuzumab (Campath )
- Cyclosporine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2020
Melanoma (Skin) Trial in Shreveport (biological, drug, procedure)
Terminated
- Melanoma (Skin)
- filgrastim
- +5 more
-
Shreveport, LouisianaLouisiana State University School of Medicine
Jun 26, 2020
Kidney Cancer, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)
Terminated
- Kidney Cancer
- +5 more
- anti-thymocyte globulin
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 29, 2020
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in United
Completed
- Acute Biphenotypic Leukemia
- +4 more
- Cyclophosphamide
- +7 more
-
Duarte, California
- +7 more
Jun 13, 2021
Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,
Completed
- Acute Myeloid Leukemia
- +12 more
- filgrastim
- +6 more
-
Minneapolis, Minnesota
- +1 more
Sep 9, 2020
Non-Neoplastic Hematologic and Lymphocytic Disorder Trial in United States (procedure, biological, drug, other, radiation)
Completed
- Non-Neoplastic Hematologic and Lymphocytic Disorder
- Allogeneic Bone Marrow Transplantation
- +11 more
-
Aurora, Colorado
- +5 more
Jul 21, 2021
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- anti-thymocyte globulin
- +7 more
-
Cleveland, OhioIreland Cancer Center at University Hospitals Case Medical Cente
Jul 23, 2020
Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in
Completed
- Blasts 10 Percent or More of Bone Marrow Nucleated Cells
- +8 more
- Cladribine
- +13 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 11, 2021
Mycosis Fungoides, Sezary Syndrome Trial run by the NHLBI (A matched peripheral donor stem cells, cyclosporine, fludarabine)
Completed
- Mycosis Fungoides
- Sezary Syndrome
- A matched peripheral donor stem cells
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2020
Kidney Cancer Trial in France (biological, drug, procedure)
Completed
- Kidney Cancer
- therapeutic allogeneic lymphocytes
- +5 more
-
Angers, France
- +25 more
Feb 23, 2021
GVHD, Leukemia, Lymphoma Trial in Minneapolis (anti-thymocyte globulin, cyclophosphamide, cyclosporine)
Withdrawn
- Graft Versus Host Disease
- +2 more
- anti-thymocyte globulin
- +7 more
-
Minneapolis, MinnesotaUniversity of Minnesota Cancer Center
Dec 31, 2019
Acute Myeloid Leukemia in Remission, de Novo Myelodysplastic Syndrome, Fanconi Anemia Trial in Brazil, United States (procedure,
Completed
- Acute Myeloid Leukemia in Remission
- +3 more
- Allogeneic Bone Marrow Transplantation
- +7 more
-
Oakland, California
- +4 more
Jan 17, 2020
Adenosine Deaminase Deficiency, Autosomal Recessive Disorder, Immune System Disorder Trial in Seattle (procedure, drug, other,
Completed
- Adenosine Deaminase Deficiency
- +6 more
- Allogeneic Bone Marrow Transplantation
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 26, 2019
Accelerated Phase of Disease, Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1
Completed
- Accelerated Phase of Disease
- +4 more
- Fludarabine Phosphate
- +7 more
-
Duarte, California
- +7 more
Jan 7, 2020
Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in
Completed
- Acute Undifferentiated Leukemia
- +63 more
- total-body irradiation
- +7 more
-
Seattle, Washington
- +1 more
Jan 17, 2020